Compare VIV & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIV | LH |
|---|---|---|
| Founded | 1973 | 1971 |
| Country | Brazil | United States |
| Employees | N/A | 70000 |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 21.7B |
| IPO Year | 1998 | 2005 |
| Metric | VIV | LH |
|---|---|---|
| Price | $15.69 | $259.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $14.80 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 876.0K | 535.6K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.35% | 1.09% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 10.46 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $9.22 | $8.26 |
| Revenue Next Year | $5.52 | $4.81 |
| P/E Ratio | ★ $22.12 | $25.15 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $9.51 | $234.16 |
| 52 Week High | $17.26 | $293.72 |
| Indicator | VIV | LH |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 39.45 |
| Support Level | $15.17 | $246.08 |
| Resistance Level | $16.47 | $275.06 |
| Average True Range (ATR) | 0.33 | 7.16 |
| MACD | -0.11 | -0.74 |
| Stochastic Oscillator | 14.85 | 7.21 |
Telefonica Brasil, known as Vivo, is the largest wireless carrier in Brazil with 102 million customers, which is equal to about 39% market share. The firm is strongest in the postpaid business, where it has 68 million customers, or about 41% share of this market. Wireless services and equipment contribute about 70% of total revenue. Vivo is the incumbent fixed-line telephone operator in Sao Paulo state and also owns an extensive fiber network across the country. The firm provides internet access to 8 million households on this network. The firm also sells pay-TV and phone services to its fixed-line customers. Finally, corporate data and IT services, including cloud computing support, contribute about 9% of total revenue.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.